Key result
Early administration of high-dose amiodarone in acute myocardial infarction increased mortality compared to placebo (16.30% vs 10.16%, P=0.04), while low-dose amiodarone had no significant effect.
RCT (n=1,073)
randomized
Absolute Event Rate: 16.3% vs 10.16%
p-value: p=0.04
No takes yet. Share an insight, caveat, or question.
High-dose amiodarone should be avoided early in AMI; challenges prior safety assumptions and calls for reevaluation of acute-phase dosing.
Marcelo V. Elizari (2000) conducted an RCT in Acute myocardial infarction (n=1,073). Amiodarone vs. Placebo was evaluated on Mortality (p=0.04). Early administration of high-dose amiodarone in acute myocardial infarction increased mortality compared to placebo (16.30% vs 10.16%, P=0.04), while low-dose amiodarone had no significant effect.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: